BioBAY微信订阅号
BioPOS微信服务号
Customers
×
Established in 2009 and headquartered in Suzhou Industrial Park, Nine Continent Company has an Engineering & Technical Research Center and two production bases located in Hangzhou(Zhejiang Province) and Taizhou(Jiangsu Province). It is a high-tech company integrating development, sales and service together. The company has a strong R&D team who has long-standing cooperation with international prestigious universities. The level of our R&D Center has reached the world best standard from its size, instruments and equipment to technology. As of now, the company has applied for 18 invention patents. Both technological innovative capabilities and scientific achievement transformation are the core motive force for NCC development. NCC concentrates on the R&D of new biopolymer products, creating value for our society and offering a good platform for the staff's continuous personal growth. Now, NCC has been widely recognized and respected by customers, which result from our technological leadership in biopolymer industry. In the future, we will not only aim at the domestic biotech markets, but also explore the overseas market actively to promote the leap development of biotech industry in China.
×
QIAGEN (Suzhou) Translational Medicine Co., Ltd. is an innovative company that provides a unique one-stop-shop from Biomarker to Companion Diagnostics Development service and Point-Of-Care product to the healthcare industry. Founded through the collaboration of two distinguished entities in the biotech industry; QIAGEN, the global leader in providing programs for companion diagnostic development to global commercialization and BioBAY; a major science and technology hub for development of the emerging biological industry in China. 1) high quality biological sample database, standardized sample preparation process and reliable clinical examination services; 2) research and development platform of biological markers from nucleic acid to protein; 3) the industry-leading "omics" data analysis, interpretation and test report generation; 4) the development and commercialization platform for the POCT products that are applicable to the tissue and humoral samples.
×
Chiral Quest was founded in 2000, we provide chemical development and contract manufacturing services to meet demand at all stages of chemical development(kilo-lab, pilot-plant and commercial scale manufacture).  Chiral Quest has a manufacturing site in Jiangxi province, headquarters and R&D centre located in Suzhou Industrial Park; and three overseas offices located in USA, Europe and India. We have expertise in asymmetric hydrogenation, multi-step synthesis and cryogenic reactions. With 13 granted U.S. patents for asymmetric hydrogenation catalysts and 8 process patents for innovative routes to generic API intermediates. Chiral Quest serves the global pharmaceutical industry with custom contract chemical development and manufacturing   services, from preclinical development to commercial supply. We have a state-of-the-art R&D laboratory, equipped with modern analytical instruments, as well as a first class manufacturing facility.  Chiral Quest has successfully developed more than 400 intermediates for Active Pharmaceutical Ingredients.  Ranging from preclinical to phase III, with four intermediates being supplied for API’s approved by the FDA.We manufacture technology advantaged products from grams to metric ton scale.
×
Founded in Suzhou Industrial Park'Biobay since 2009,Lisure Science company is a leading design and manufacturing company of automatic instrument and equipment system in Bio&Chemical. Our systems have been widely used by global pharmaceutical companies ,scientific research institutions and CRO company. Lisure Science's success is based on many years of experience in drug methodologies .chromatography and expertise in precision machining and automation. Our R&D team consists of industry professional with expertise in chemistry, biological, mechanical &electrical engineering. Collectively, we have been developing optimized configurations and solutions to meet the most demanding and challenging applications. Our 30,000 square feet R&D and manufacturing facility with advanced CNC machinery and application lab passed IS09001 certification in 2010.  In additional to serve end users directly, we are also willing to serve international customers as OEM&ODM supplier, We can perform special design, assembly .parts or module manu-facturing. Software development, and system integration for OEM &ODM customers. We welcome big or small opportunities to serve our customers.
×
Synbio Technologies is building up the first integrated GPS (Genotype, Phenotype and Synotype) system aimed to a quick and easy translation or reverse translation between "Genotype" and "Phenotype" by using our proprietary "Synotype" platform. The company's scientific capabilities encompass areas such as DNA engineering, DNA synthesis, genome synthesis, pathway synthesis, synthetic biology, pharmacogenomics, microbiology, translational biology and the applications of synthetic biology. Synbio Technologies' team has a proven track record regarding translating scientific breakthroughs into cost effective biological solution. The “GPS” represents “Genotype”, “Phenotype” and “Synotype”. Synbio Technologies’ Synotype platform was conceived, designed and implemented with synthetic biology technology to produce: A novel approach to deepen our knowledge on genotying (reading by writing); A simple approach to characterize phenotyping (understanding by writing); A quick approach to study the correlations of genotyping and phenotyping (linking by writing); A cost effective approach to design and produce the novel sequence and subsequent function traits (creating by writing).
×
Suzhou GenePharma is recognized world-wide as a leading provider of RNA Phosphoramidites, DNA Phosphoramidites, Special Monomers, Modifiers Reagents, Fuolrescent Labeling Reagents, Special Labeling Reagents. GenePharma was founded in Suzhou Industrial Park in 2007 by a few scientists who have worked in various western countries. The company has all the internationally leading core technologies of DNA/RNA chemical synthesis reagents. It has a high-quality workforce, with chemical, biological, or related professional background, and it always treats "Dedication, Enthusiasm, Unity, and Innovation" as its code of conduct. The R&D team is led by senior scientists who have studied and worked aboard for many years and the experienced staff, many of whom have a masters or doctorate degree. The company’s products cover chemically-synthetic DNA/RNA phosphoramidites, Terminus modifiers, 3’-modification supports, Fluorescein dyes, Rhodamine dyes, Quenchers, Cyanine dyes, Biotin and chemical phosphorylation and so on. Our company is located in the Suzhou Industrial Park. It provides employees with a good working environment and approximately 10000 square meters of modern plant, clean and orderly production areas, R&D areas and office areas, which also guarantee us to produce high-quality products continuously and stably.
×
As a global leader in R&D genomics services, GENEWIZ leads the way in providing superior data quality with unparalleled technical support to enable researchers around the world to advance their scientific discoveries faster than ever before. Our customers at top-tier pharmaceutical, biotechnology, and academic institutions, as well as cutting-edge start-ups, rely on GENEWIZ's proprietary technologies for consistent, reliable, high-quality data, even on the most difficult projects. A full-service provider, GENEWIZ provides Sanger DNA sequencing, gene synthesis, molecular biology, high throughput/next generation sequencing, bioinformatics, and GLP regulatory services. Today, GENEWIZ has the largest network of genomics laboratories around the world. Our customers are supported by major investments in state-of-the-art facilities, rigorous quality systems based on Good Laboratory Practice (GLP), and highly-qualified scientific teams. GENEWIZ also holds the ISO:9001:2008 Quality Management Certification, a voluntary international certification noting operational excellence and quality standards. Backed by our 99.9% completion rate, GENEWIZ can synthesize naturally occurring sequences, codon-optimized genes, gene libraries, complex sequences, large sequences, or any other sequence you need for your research--no matter the difficulty level. With industry-leading Ph.D.-level technical support to proactively communicate and troubleshoot technical difficulties, it's no wonder top research labs and pharma/biotech companies around the world rely on GENEWIZ's proprietary protocols to synthesize their long and difficult DNA sequences.Our streamlined process offers timely and dependable results, giving you the flexibility to focus on other research priorities. Simply submit your nucleotide or amino acid sequence, and GENEWIZ will deliver it exactly as ordered.
×
Crystal Pharmatech is a technology-driven contract research organization (CRO) that focuses on materials science and engineering for drug development. We partner with clients to ensure comprehensive solutions for their needs in solid-state research, crystallization process development, and preformulation studies. We guide clients in the discovery and selection of the optimal solid phase for drug development using all aspects of pre-formulation studies, including API process and formulation development, regulatory support and intellectual property protection. Founded in 2010, Crystal Pharmatech has business relationships with over 200 global pharmaceutical companies. High quality service, a culture of confidentiality, and fast turnaround with cost-effective pricing are our trademarks. As we continue to grow, Crystal Pharmatech will always keep customers our number one priority. We will also continue to be at the forefront of innovation in the field of solid-state chemistry so that our customers can reap the benefits of key discoveries in an ever changing field. Our Scientific Advisory Board includes global leaders in drug development covering amorphous dispersions, co-crystals, crystallization, solid forms, formulation and pre-formulation. The role of our board is all encompassing while we search for new scientific areas for internal and external projects.
×
The company has a third-party medical testing agency. In addition to the routine clinical testing services, also on the cardiovascular disease, individualized treatment, high-risk tumors single gene diseases and infectious diseases. Play an important role in disease prevention, early screening, differential diagnosis, prognosis assessment and individualized medication. It has now completed hundreds of thousands of clinical specimens and accumulated a large number of clinical data and biological samples.
×
Company is committed to build the whole dimension of pharmaceutical affairs platform in the field of pharmacy to promote healthy industry in the following three aspects: (1) make it possible of the independent third party professional pharmacy; (2) platform provides professional support and innovative means for health industry institutions with third-party health management big data; (3) makes it possible to full health management services for individuals, will effectively reduce preventable medication problem, not only to bring the government and residents in lower cost (such as health care), and provided a better method to the public health management.
×
Company is committed to build the whole dimension of pharmaceutical affairs platform in the field of pharmacy to promote healthy industry in the following three aspects: (1) make it possible of the independent third party professional pharmacy; (2) platform provides professional support and innovative means for health industry institutions with third-party health management big data; (3) makes it possible to full health management services for individuals, will effectively reduce preventable medication problem, not only to bring the government and residents in lower cost (such as health care), and provided a better method to the public health management.
×
Headquartered in Delaware USA, Sepax Technologies, Inc. is a privately held company founded in November 2002. Sepax focuses on customers’ needs and provides solutions to customer’s challenges in chromatographic separation science. Sepax develops and manufactures HPLC consumables, bulk media, and equipment for chemical and biological separations in liquid chromatography. Sepax is a fast growing technology company and has emerged as a leader in the biological separation industry. Sepax has been developing wide range of intellectual properties in the areas of particle synthesis, surface modification, LC column packing, bulk media production, and purification process development. Sepax Quality Management System is ISO 9001:2008 certified. Sepax Technologies, Inc. focuses on three business areas: 1) bioanalytical solutions, 2) solution based process purification and 3) medical diagnostics.In bioanalytical area, we provide comprehensive LC column products and services to meet the needs of each market fragment of the biomolecules separation and analysis.For process chromatography, we provide solutions to customers’ needs for various scales of the purification, including process development, bulk media and equipment.Our innovative technologies deliver unique products for medical diagnostics, such as GlyHb, a high resolution product for diagnosis of diabetes.
×
Based on a good government resources platform, combined with its own proprietary technology and capital advantage, and using the characteristic of IBAD + MOCVD technical route and characteristic of the heavy doping strong magnetic flux pinning REBCO superconductor thin film preparation methods, professional research and development of the second generation of high temperature superconducting strip preparation technology industrialization of low cost, high yield rate. The second generation of high temperature superconducting strip achieve some important application by its unique zero resistance high load flow density and completely diamagnetic characteristic in medical treatment, scientific research and military and other fields. Company has made significant breakthrough, the second generation of high temperature superconducting strip of various technical indicators have reached the world advanced level, changed the situation of the dependence on imported materials.